Vaccine/Sample
stringclasses 7
values | Dose
stringclasses 19
values | Geography Type
stringclasses 2
values | Geography
stringclasses 79
values | Survey Year
stringclasses 19
values | Dimension Type
stringclasses 6
values | Dimension
stringclasses 16
values | Estimate (%)
float64 0.4
100
⌀ | 95% CI (%)
stringlengths 10
13
⌀ | Sample Size
float64 30
91.7k
⌀ |
|---|---|---|---|---|---|---|---|---|---|
Varicella | History of disease | States/Local Areas | Kentucky | 2011 | Age | 13-17 Years | 45.9 | 39.3 to 52.6 | 382 |
Varicella | History of disease | States/Local Areas | Kentucky | 2015 | Age | 13-17 Years | 19.1 | 14.5 to 24.7 | 330 |
Varicella | History of disease | States/Local Areas | Kentucky | 2014 | Age | 13-17 Years | 20.6 | 15.6 to 26.7 | 335 |
Varicella | History of disease | States/Local Areas | Maine | 2008 | Age | 13-17 Years | 69.4 | 63.5 to 74.7 | 333 |
Varicella | History of disease | States/Local Areas | Maine | 2009 | Age | 13-17 Years | 61.8 | 55.1 to 68.0 | 299 |
Varicella | History of disease | States/Local Areas | Maine | 2014 | Age | 13-17 Years | 20.1 | 15.6 to 25.5 | 341 |
Varicella | History of disease | States/Local Areas | Maine | 2018 | Age | 13-17 Years | 6.6 | 4.3 to 10.0 | 317 |
Varicella | History of disease | States/Local Areas | Maine | 2015 | Age | 13-17 Years | 18.8 | 14.6 to 24.0 | 374 |
Varicella | History of disease | States/Local Areas | Maine | 2010 | Age | 13-17 Years | 50.4 | 44.1 to 56.8 | 312 |
Varicella | History of disease | States/Local Areas | Maine | 2011 | Age | 13-17 Years | 38 | 32.4 to 43.9 | 411 |
Varicella | History of disease | States/Local Areas | Maine | 2013 | Age | 13-17 Years | 30.8 | 25.4 to 36.8 | 343 |
Varicella | History of disease | States/Local Areas | Maine | 2012 | Age | 13-17 Years | 34.8 | 28.6 to 41.5 | 319 |
Varicella | History of disease | States/Local Areas | Maine | 2016 | Age | 13-17 Years | 15.4 | 11.4 to 20.6 | 347 |
Varicella | History of disease | States/Local Areas | Maine | 2019 | Age | 13-17 Years | 10.1 | 6.5 to 15.3 | 316 |
Varicella | History of disease | States/Local Areas | Maine | 2020 | Age | 13-17 Years | 9.8 | 6.8 to 14.1 | 372 |
Varicella | History of disease | States/Local Areas | Maine | 2021 | Age | 13-17 Years | 7.4 | 4.5 to 11.9 | 293 |
Varicella | History of disease | States/Local Areas | Maine | 2022 | Age | 13-17 Years | 6.8 | 3.9 to 11.6 | 268 |
Varicella | History of disease | States/Local Areas | Maine | 2017 | Age | 13-17 Years | 13.5 | 10.1 to 17.9 | 347 |
HPV | Up-to-Date, Females | States/Local Areas | Maine | 2019 | Age | 13-15 Years | 42.1 | 30.3 to 55.0 | 95 |
HPV | Up-to-Date, Females | States/Local Areas | Maine | 2020 | Age | 13-15 Years | 60 | 48.9 to 70.2 | 108 |
HPV | Up-to-Date, Females | States/Local Areas | Maine | 2018 | Age | 13-15 Years | 44.8 | 33.2 to 57.0 | 100 |
Tetanus | ≥1 Dose Td or Tdap | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 92.3 | 87.4 to 95.3 | 273 |
HPV | Up-to-Date, Males | States/Local Areas | New Hampshire | 2023 | Age | 13-15 Years | 54.5 | 42.6 to 65.9 | 92 |
HPV | Up-to-Date, Females | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 75.1 | 64.4 to 83.5 | 118 |
Varicella | ≥2 Doses with no disease history | States/Local Areas | New Hampshire | 2023 | Age | 13-15 Years | 96.8 | 93.0 to 98.6 | 149 |
HPV | Up-to-Date, Females | States/Local Areas | New Hampshire | 2023 | Age | 13-15 Years | 68.9 | 53.7 to 80.9 | 66 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2023 | Age | 13-15 Years | 61.3 | 51.9 to 70.0 | 158 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2023 | Age | 13-15 Years | 90.2 | 83.0 to 94.6 | 158 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2023 | Age | 13-15 Years | 90.3 | 83.3 to 94.5 | 158 |
≥2 Doses Hep A | null | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 89.3 | 83.7 to 93.1 | 273 |
Varicella | History of disease | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 4.9 | 2.8 to 8.5 | 273 |
Varicella | ≥1 Dose with no disease history | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 97.1 | 94.2 to 98.5 | 259 |
Varicella | ≥2 Doses with no disease history | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 96.1 | 93.2 to 97.8 | 259 |
Varicella | ≥2 Doses or history of disease | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 96.3 | 93.5 to 98.0 | 273 |
≥2 Doses MMR | null | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 96.2 | 92.7 to 98.0 | 273 |
≥3 Doses HepB | null | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 94.8 | 90.7 to 97.1 | 273 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 70.6 | 63.8 to 76.5 | 273 |
HPV | Up-to-Date, Males | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 66.2 | 57.3 to 74.2 | 155 |
HPV | ≥1 Dose, Females | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 87.6 | 78.5 to 93.2 | 118 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 85.6 | 80.2 to 89.7 | 273 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 93.4 | 89.1 to 96.1 | 273 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 91.8 | 87.0 to 95.0 | 273 |
HPV | ≥1 Dose, Males | States/Local Areas | New Hampshire | 2023 | Age | 13-17 Years | 83.7 | 76.4 to 89.1 | 155 |
HPV | ≥2 Doses, Males and Females | States/Local Areas | New Hampshire | 2022 | Age | 13-17 Years | 76.7 | 69.9 to 82.4 | 225 |
HPV | ≥2 Doses, Males | States/Local Areas | New Hampshire | 2022 | Age | 13-17 Years | 75.9 | 66.1 to 83.6 | 116 |
HPV | ≥2 Doses, Females | States/Local Areas | New Hampshire | 2022 | Age | 13-17 Years | 77.7 | 67.5 to 85.4 | 109 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Overall | Overall | 81.1 | 78.5 to 83.4 | 1,524 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2018-2022 | Urbanicity | Living In a Non-MSA | 94.5 | 91.7 to 96.3 | 608 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Overall | Overall | 69.6 | 66.7 to 72.3 | 1,524 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Urbanicity | Living In a Non-MSA | 77.5 | 72.9 to 81.6 | 608 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Urbanicity | Living In a MSA Non-Principal City | 83.3 | 79.7 to 86.3 | 716 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Urbanicity | Living In a MSA Principal City | 81.7 | 74.4 to 87.2 | 200 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Urbanicity | Living In a Non-MSA | 65.6 | 60.5 to 70.3 | 608 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Urbanicity | Living In a MSA Non-Principal City | 72.6 | 68.6 to 76.2 | 716 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Urbanicity | Living In a MSA Principal City | 68.6 | 60.5 to 75.8 | 200 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2018-2022 | Urbanicity | Living In a Non-MSA | 81.5 | 77.3 to 85.2 | 608 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2018-2022 | Urbanicity | Living In a MSA Non-Principal City | 92.8 | 90.2 to 94.7 | 716 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2018-2022 | Urbanicity | Living In a MSA Principal City | 89.1 | 82.5 to 93.5 | 200 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Race and Ethnicity | Hispanic | 84.6 | 73.6 to 91.6 | 87 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2018-2022 | Urbanicity | Living In a MSA Non-Principal City | 94.4 | 92.0 to 96.2 | 716 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2018-2022 | Urbanicity | Living In a MSA Principal City | 96.6 | 92.9 to 98.4 | 200 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2018-2022 | Race and Ethnicity | Other or Multiple Races, Non-Hispanic | 91.4 | 84.6 to 95.4 | 133 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Race and Ethnicity | White, Non-Hispanic | 68.4 | 65.2 to 71.5 | 1,287 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Race and Ethnicity | Other or Multiple Races, Non-Hispanic | 85.5 | 76.5 to 91.4 | 133 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Race and Ethnicity | Other or Multiple Races, Non-Hispanic | 77.9 | 68.3 to 85.2 | 133 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Race and Ethnicity | Hispanic | 69.9 | 57.0 to 80.3 | 87 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2018-2022 | Race and Ethnicity | White, Non-Hispanic | 88.3 | 86.0 to 90.3 | 1,287 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2018-2022 | Race and Ethnicity | White, Non-Hispanic | 95 | 93.3 to 96.2 | 1,287 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2018-2022 | Race and Ethnicity | Hispanic | 84.9 | 73.6 to 91.9 | 87 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2018-2022 | Race and Ethnicity | Hispanic | 93.9 | 87.6 to 97.2 | 87 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2018-2022 | Race and Ethnicity | Other or Multiple Races, Non-Hispanic | 95.1 | 88.2 to 98.0 | 133 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Race and Ethnicity | White, Non-Hispanic | 80.3 | 77.5 to 82.9 | 1,287 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Poverty | Below Poverty Level | 78.2 | 67.4 to 86.1 | 105 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Poverty | Living At or Above Poverty Level | 81.3 | 78.6 to 83.7 | 1,375 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2018-2022 | Poverty | Below Poverty Level | 82.5 | 72.5 to 89.5 | 105 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2018-2022 | Poverty | Living At or Above Poverty Level | 89 | 86.9 to 90.9 | 1,375 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Poverty | Below Poverty Level | 66.5 | 55.1 to 76.2 | 105 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Poverty | Living At or Above Poverty Level | 69.9 | 66.9 to 72.8 | 1,375 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2018-2022 | Poverty | Living At or Above Poverty Level | 94.5 | 92.8 to 95.8 | 1,375 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2018-2022 | Poverty | Below Poverty Level | 95.1 | 86.4 to 98.3 | 105 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Private Insurance Only | 90.7 | 88.6 to 92.5 | 1,058 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Any Medicaid | 83.9 | 78.6 to 88.0 | 361 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Private Insurance Only | 83.9 | 81.1 to 86.4 | 1,058 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Any Medicaid | 76.7 | 70.9 to 81.6 | 361 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Other | 88.3 | 75.3 to 94.9 | 72 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Other | 73.6 | 59.2 to 84.3 | 72 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Private Insurance Only | 72.5 | 69.2 to 75.6 | 1,058 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Uninsured | 74.5 | 49.0 to 89.9 | 33 |
HPV | ≥1 Dose, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Uninsured | 68.9 | 45.1 to 85.6 | 33 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Any Medicaid | 66 | 59.8 to 71.7 | 361 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Other | 56.1 | 41.8 to 69.4 | 72 |
HPV | Up-to-Date, Males and Females | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Uninsured | 61 | 38.7 to 79.4 | 33 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Private Insurance Only | 95.9 | 94.2 to 97.0 | 1,058 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Any Medicaid | 92.9 | 89.1 to 95.4 | 361 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Other | 93.1 | 79.3 to 98.0 | 72 |
Tetanus | ≥1 Dose Tdap | States/Local Areas | New Hampshire | 2018-2022 | Insurance Coverage | Uninsured | 89.4 | 64.3 to 97.5 | 33 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2009 | Age | 13-17 Years | 67.8 | 61.6 to 73.5 | 307 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2008 | Age | 13-17 Years | 54.6 | 47.3 to 61.7 | 300 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2011 | Age | 13-17 Years | 80.6 | 74.9 to 85.3 | 385 |
≥1 Dose MenACWY | null | States/Local Areas | New Hampshire | 2010 | Age | 13-17 Years | 73.8 | 68.1 to 78.8 | 350 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.